IOL Chemicals and Pharmaceuticals Ltd

NSE: IOLCP · BSE: 524164 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹204.19
Market cap: ₹5,994 Cr
Revenue (annual): ₹2,319 Cr
Net profit (annual): ₹137.6 Cr
P/E (TTM): 35.6×Sector 50.4×
Promoter holding: 62.28%+4.80% QoQ
FII holding: 4.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Capacity Expansion 2 Regulatory Approval 1 Other Announcement 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

9 Sep 2026 18:06 IST NSE

Capacity ExpansionAlfa Alert

IOL Chemicals and Pharmaceuticals Capacity Expansion: ₹350 Cr Investment

IOL Chemicals and Pharmaceuticals Ltd will expand Ibuprofen capacity by 6,000 MTPA. The project, requiring a ₹350 Crore investment, is expected to be commercialized by December 2027.

Value: ₹350.0 Cr
Execution: December 2027
manufacturing capacity: 6000.0 MTPA

Read the filing ↗

9 Sep 2026 14:33 IST BSE

Capacity ExpansionAlfa Alert

IOL Chemicals and Pharmaceuticals Capacity Expansion: ₹495 Cr Investment

IOLCP announces three capacity expansions at Barnala: 6,000 MTPA Ibuprofen unit, CDMO formulation facility, and specialty chemicals tolling plant. Total investment ₹495 Crore funded via internal accruals.

Value: ₹495.0 Cr
ibuprofen manufacturing capacity: 6000 MTPA

Read the story on ALFA News Read the filing ↗